September 11, 2023 | Press Release
NATICK, MA – September 11, 2023 – Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced that it has added two senior executives to the Company’s leadership team as it continues development...April 24, 2023 | Press Release
NATICK, MA – April 24, 2023 – (Business Wire) Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced the appointment of Myla Lai-Goldman, MD, to its Board of Directors. “Myla’s visionary...April 3, 2023 | Press Release
NATICK, MA – April 03, 2023 – (Business Wire) Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced it has closed a $41 million Series A financing round. The oversubscribed financing was...March 23, 2023 | Press Release
NATICK, MA – March 23, 2023 – (Business Wire) Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced that it has added two senior executives as the Company transitions from research to...February 15, 2023 | Press Release
NATICK, MA – February 15, 2023 – (Business Wire) Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced that Dawn Mattoon, PhD, has assumed the role of Chief Executive Officer and a...July 11, 2022 | Press Release
NATICK, MA – July 11, 2022 – Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced the appointment of experienced biotechnology executive, Dawn Mattoon, PhD, as Chief Operating Officer,...